Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400196 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, 2024. Verfasst von Tushar Ranjan Panda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicinal Chemistry and Cell Biology, Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Navy N…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Organoplatinum Compounds. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 110 Literaturangaben. Gefördert von: Department of Atomic Energy, Tata Institute of Fundamental Research, Department of Atomic Energy, Government of India.
Abstract (Originalsprache)
The search for better chemotherapeutic drugs to alleviate the deficiencies of existing platinum (Pt) drugs has picked up the pace in the millennium. There has been a disparate effort to design better and safer Pt drugs to deal with the problems of deactivation, Pt resistance and toxic side effects of clinical Pt drugs. In this review, we have discussed the potential of kinetically inert Pt complexes as an emerging class of next‐generation Pt drugs. The introduction gives an overview about the development, use, mechanism of action and side effects of clinical Pt drugs as well as the various approaches to improve some of their pharmacological properties. We then describe the impact of kinetic lability on the pharmacology of functional Pt drugs including deactivation, antitumor efficacy, toxicity and resistance. Following a brief overview of numerous pharmacological advantages that a non‐functional kinetically inert Pt complex can offer; we discussed structurally different classes of kinetically inert Pt (II) complexes highlighting their unique pharmacological features.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Medicinal Chemistry and Cell Biology, Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Navy Nagar, 400005, Mumbai, India.
ORCID-Profile: Tushar Ranjan Panda, Malay Patra
Förderung
- Department of Atomic Energy
- Tata Institute of Fundamental Research
- Department of Atomic Energy, Government of India
Zitieren
APA
Panda, T. R., & Patra, M. (2024). Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead. ChemMedChem. https://doi.org/10.1002/cmdc.202400196
Vancouver
Panda TR, Patra M. Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead. ChemMedChem. 2024. doi:10.1002/cmdc.202400196
BibTeX
@article{Panda2024,
author = {Panda, Tushar Ranjan and Patra, Malay},
title = {Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400196}
}
EUVIMED